Sanofi Pasteur to control Shantha Biotechnics through Mérieux Alliance

Sanofi-Pasteur, the vaccines division of sanofi-aventis Group, has acquired ShanH, French subsidiary of Merieux Alliance, which is holding majority stake in Hyderabad-based Shantha Biotechnics. 

Under the terms of the agreement, Sanofi Pasteur will support Shantha's ongoing development as a platform to address the need for high quality affordable vaccination in international markets.

Alain Mérieux will chair the board of ShanH and a new joint committee will be created to be chaired by Alain Mérieux on vaccine strategy for the emerging markets. Dr Varaprasad Reddy, the founder of Shantha Biotechnics in 1993, will continue to lead the company as managing director.